Get the Stockscreener App
0.958
2.22%
-0.0218
Allarity Therapeutics Inc stock is traded at $0.958, with a volume of 209.44K.
It is down -2.22% in the last 24 hours and down -5.15% over the past month.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$0.9798
Open:
$0.98
24h Volume:
209.44K
Relative Volume:
0.47
Market Cap:
$14.45M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00465
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
-1.24%
1M Performance:
-5.15%
6M Performance:
-2.06%
1Y Performance:
+489.54%
1-Day Range:
$0.94
$0.98
1-Week Range:
$0.93
$1.01
52-Week Range:
$0.1131
$3.95
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics Inc
Sector
Industry
Phone
401-426-4664
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
0.958 | 14.77M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Stock (ALLR) Latest News
Allarity Therapeutics Inc. stock volume spike explainedInsider Selling & Free Daily Entry Point Trade Alerts - Newser
Chart based analysis of Allarity Therapeutics Inc. trends2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser
Order flow analysis tools used on Allarity Therapeutics Inc.2025 Trading Recap & Technical Entry and Exit Alerts - Newser
Advanced analytics toolkit walkthrough for Allarity Therapeutics Inc.2025 Breakouts & Breakdowns & Verified Entry Point Detection - Newser
Allarity Therapeutics Delays 10-Q Filing - MSN
How Allarity Therapeutics Inc. stock performs during market volatilityEarnings Growth Report & Precise Swing Trade Entry Alerts - Newser
Short interest data insights for Allarity Therapeutics Inc.Quarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP - Bluefield Daily Telegraph
Allarity Therapeutics, Inc. SEC 10-Q Report - TradingView
Allarity Therapeutics Provides Second Quarter 2025 Update, - GlobeNewswire
First Patients Dosed: Allarity's Dual-Action Cancer Drug Stenoparib Enters Critical Phase 2 Trial - Stock Titan
Will Allarity Therapeutics Inc. bounce back from current support2025 Historical Comparison & Entry Point Strategy Guides - Newser
Will Allarity Therapeutics Inc. stock benefit from interest rate changesJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - Newser
Volatility clustering patterns for Allarity Therapeutics Inc.2025 Dividend Review & Verified Entry Point Signals - Newser
Chart overlay techniques for tracking Allarity Therapeutics Inc.New Guidance & Safe Entry Momentum Tips - Newser
Identifying reversal signals in Allarity Therapeutics Inc.Market Risk Analysis & Weekly High Potential Alerts - Newser
Why Allarity Therapeutics Inc. stock attracts strong analyst attentionEarnings Beat & High Accuracy Swing Entry Alerts - Newser
How to use Fibonacci retracement on Allarity Therapeutics Inc.July 2025 Snapshot & Fast Moving Market Watchlists - Newser
Statistical indicators supporting Allarity Therapeutics Inc.’s strengthMarket Growth Report & Comprehensive Market Scan Reports - Newser
Allarity Therapeutics Inc. Included in Top Momentum ScanWeekly Trading Summary & Reliable Price Breakout Signals - newsyoung.net
Earnings visualization tools for Allarity Therapeutics Inc.Weekly Trade Analysis & Consistent Income Trade Ideas - Newser
Price action breakdown for Allarity Therapeutics Inc.Quarterly Market Summary & AI Enhanced Execution Alerts - Newser
Is Allarity Therapeutics Inc. the Top Chart Pick This WeekJuly 2025 Chart Watch & Target Return Focused Stock Picks - newsyoung.net
Analyzing Allarity Therapeutics Inc. with multi timeframe chartsPortfolio Profit Report & Stock Market Timing Techniques - Newser
Top chart patterns to watch in Allarity Therapeutics Inc.July 2025 Sentiment & Fast Momentum Entry Tips - Newser
Momentum divergence signals in Allarity Therapeutics Inc. chart2025 Year in Review & Stock Portfolio Risk Control - Newser
What machine learning models say about Allarity Therapeutics Inc.July 2025 Decliners & Daily Stock Trend Reports - Newser
Identifying reversal signals in Allarity Therapeutics Inc. [July 2025 Intraday Action]AI Powered Market Entry Ideas - Newser
What MACD signals say about Allarity Therapeutics Inc.Free Early Entry Picks Before News Breakout - Newser
Strategies to average down on Allarity Therapeutics Inc.Weekly Chart Watchlist with Trade Guidance - Newser
Does Allarity Therapeutics Inc. fit your quant trading modelForecast Model for Intraday Buy Signals - Newser
Is Allarity Therapeutics Inc. affected by consumer sentimentPositive Outlook Long-Term Picks - newsyoung.net
Custom watchlist performance reports with Allarity Therapeutics Inc.Short-Term Trade Setup with Forecast Insight - Newser
Using RSI to spot recovery in Allarity Therapeutics Inc.Momentum Detection with Entry Optimization - Newser
Is Allarity Therapeutics Inc. forming a reversal patternEarly Entry Ideas with Momentum Potential - Newser
Allarity Therapeutics Inc Stock (ALLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):